Expect more tuck-in M&A, portfolio pruning in medtech, execs say

T2Covered by 1 source · first reported by BioPharma Dive / Healthcare Dive / MedTech Dive at 21 Oct, 12:53 UTC

As medical device makers face “finite” capital, portfolio reshaping will likely remain a focus in the sector.

science

Sources

• T2Expect more tuck-in M&A, portfolio pruning in medtech, execs sayBioPharma Dive / Healthcare Dive / MedTech Dive21 Oct, 12:53